A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

The only licensed vaccine on the market—the Bacille Calmette-Guerin (BCG) vaccine—was invented more than 100 years ago and ...

ImmunityBio, Inc. a annoncé que U.S. Urology Partners est l'un des premiers fournisseurs à participer au programme d'accès ...

L’administration Trump souffle le chaud et le froid sur le financement des programmes de lutte contre cette maladie ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

Michigan has the only persisting bovine tuberculosis outbreak in wild deer anywhere in the U.S. — and it occasionally spills ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

The BCG Vaccine Laboratory (BCGVL), under the Directorate General of Health Services, Ministry of Health & Family Welfare, is ...